Reverse-Phase Protein Array Analysis to Identify Biomarker Proteins in Human Pancreatic Cancer

被引：0
作者：
Yu-Jing Huang
Marsha L. Frazier
Nianxiang Zhang
Qian Liu
Chongjuan Wei
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Epidemiology, Unit 1365
[2] The University of Texas MD Anderson Cancer Center,Department of Bioinformatics and Computational Biology
来源：
Digestive Diseases and Sciences | 2014年 / 59卷
关键词：
Pancreatic cancer; Reverse-phase protein arrays; Proteomic profiling; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：968 / 975
页数：7
相关论文
共 329 条
  • [1] Siegel R(2012)Cancer statistics, 2012 CA Cancer J Clin 62 10-29
  • [2] Naishadham D(2007)Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer J Clin Oncol 25 2607-2615
  • [3] Jemal A(2005)Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial Lancet Oncol 6 369-376
  • [4] Sultana A(2004)Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate J Clin Oncol 22 3776-3783
  • [5] Smith CT(2009)Diagnostic and prognostic biomarkers in pancreatic carcinoma Int J Clin Exp Pathol 2 1-10
  • [6] Cunningham D(2007)Early detection and biomarkers in pancreatic cancer J Natl Compr Canc Netw 5 1034-1041
  • [7] Starling N(2010)Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report Ann Oncol 21 441-447
  • [8] Neoptolemos JP(2005)Molecular prognostic markers in pancreatic cancer: a systematic review Eur J Cancer 41 2213-2236
  • [9] Ghaneh P(1990)The clinical utility of the CA 19-9 tumor-associated antigen Am J Gastroenterol 85 350-355
  • [10] Reni M(2003)Proteomic applications for the early detection of cancer Nat Rev Cancer 3 267-275
12345678910